|
|
Article: Validation problems and FDA reporting lapses result in 8-point 483 for Stryker.(MEDICAL DEVICES)
- Article from:
- Inspection Monitor
- Article date:
- January 1, 2009
CopyrightCOPYRIGHT 2009 Washington Information Source, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Stryker Orthopaedics, Mahwah, NJ Parsippany District
Stryker was cited for failing to submit reports of corrections and removals to FDA when recalling out-of-specification orthopedic implants, among other GMP non-conformities, following an inspection June 1-July 12, 2007.
FDA investigator Li Li observed that Stryker conducted three market withdrawals during 2006 and 2007 that were not reported to FDA.
On March 9, 2006, the company withdrew units of Trident PSL Acetabular Shells "due to a discovery of a machine operator's failures to inspect product dimensional features prior to release and out-of-specification features from parts machined by the ...